1S,3R-ACPD-PREFERRING INWARD CURRENT IN RAT DORSOLATERAL SEPTAL NEURONS IS MEDIATED BY A NOVEL EXCITATORY AMINO-ACID RECEPTOR

被引:19
|
作者
ZHENG, F [1 ]
HASUO, H [1 ]
GALLAGHER, JP [1 ]
机构
[1] UNIV TEXAS, MED BRANCH, DEPT PHARMACOL & TOXICOL, GALVESTON, TX 77555 USA
关键词
METABOTROPIC GLUTAMATE RECEPTORS (MGLURS); EXCITATORY AMINO ACID (EAA) RECEPTORS; INWARD CURRENT; PERTUSSIS TOXIN; IS; 3R-ACPD; GTP-BINDING PROTEINS; SEPTAL NEURONS;
D O I
10.1016/0028-3908(95)00047-A
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Metabotropic glutamate receptors (mGluRs) form a receptor family that consists of diverse receptor subtypes; now, numbering 8-exclusive of splice variants. (1S,3R)-1-aminocycropentane-1,3-dicarboxylic acid (1S,3R-ACPD) has been suggested to be a selective agonist for the mCluRs. We have recently reported that, in rat dorsolateral septal nucleus (DLSN) neurones, a 1S,3R-ACPD-preferring inward current (ACPD(i)) persists in pertussis toxin-treated rats. We now report that this ACPD(i)-current: (1) persists in DLSN neurones dialyzed with a stable analog of GTP, namely, GTP gamma S; (2) exhibits a negative slope region with inward rectification in its I-V relationship; (3) persists in neurones superfused with tetrodotoxin or low calcium solutions; (4) is dependent upon both sodium and calcium ions; and (5) is independent of a reduction in temperature. Furthermore, pharmacological data suggest that this current may be activated by a unique type of excitatory amino acid (EAA) receptor, i.e. a receptor which prefers ''metabotropic'' EAA agonists and is insensitive to AP5 or CNQX. Activation by ACPD of inward currents associated with a conductance increase have also been reported at cultured mouse cerebellar Purkinje neurones; in slices of rat hippocampal CAI neurones and slice cultures of hippocampal CA3 neurones. We suggest that this ACPD(i) current may play an important role within the CNS in the induction of long-term potentiation and other neurological processes; processes attributed previously to currents associated with NMDA receptor activation.
引用
收藏
页码:905 / 917
页数:13
相关论文
共 41 条
  • [31] Asymmetric synthesis and receptor pharmacology of the group II mGlu receptor ligand (1S,2R,3R,5R,6S)-2-amino3-hydroxy-bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid -: HYDIA
    Woltering, Thomas J.
    Adam, Geo
    Huguenin, Philipp
    Wichmann, Juergen
    Kolczewski, Sabine
    Gatti, Silvia
    Bourson, Anne
    Kew, James N. C.
    Richards, Grayson
    Kemp, John A.
    Mutel, Vincent
    Knoflach, Frederic
    CHEMMEDCHEM, 2008, 3 (02) : 323 - 335
  • [32] Microinfusion of the metabotropic glutamate receptor agonist 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid into the nucleus accumbens induces dopamine-dependent locomotor activation in the rat
    Attarian, S
    Amalric, M
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1997, 9 (04) : 809 - 816
  • [33] L-2-AMINO-4-PHOSPHONOBUTANOIC ACID AND 1S,3R-1-AMINOCYCLOPENTANE-1,3-DICARBOXYLIC ACID REDUCE PAIRED-PULSE DEPRESSION RECORDED FROM MEDIAL PERFORANT PATH IN THE DENTATE GYRUS OF RAT HIPPOCAMPAL SLICES
    KAHLE, JS
    COTMAN, CW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 266 (01): : 207 - 215
  • [34] Discovery of a novel and potent human and rat β3-adrenergic receptor agonist, [3-[(2R)-[[(2R)-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1H-indol-7-yloxy]acetic acid
    Harada, H
    Hirokawa, Y
    Suzuki, K
    Hiyama, Y
    Oue, M
    Kawashima, H
    Kato, H
    Yoshida, N
    Furutani, Y
    Kato, S
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2005, 53 (02) : 184 - 198
  • [35] (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid-induced increases in cyclic AMP formation in the neonatal rat hippocampus are mediated by a synergistic interaction between phosphoinositide- and inhibitory cyclic AMP-coupled mGluRs
    Schoepp, DD
    Johnson, BG
    Monn, JA
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 (05) : 1981 - 1985
  • [36] Discovery of (1S,2R,3S,4S,5R,6R)-2-Amino-3-[(3,4-difluorophenyl)sulfanylmethyl]-4-hydroxy-bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Hydrochloride (LY3020371•HCl): A Potent, Metabotropic Glutamate 2/3 Receptor Antagonist with Antidepressant-Like Activity
    Chappell, Mark D.
    Li, Renhua
    Smith, Stephon C.
    Dressman, Bruce A.
    Tromiczak, Eric G.
    Tripp, Allie E.
    Blanco, Maria-Jesus
    Vetman, Tatiana
    Quimby, Steven J.
    Matt, James
    Britton, Thomas C.
    Fivush, Adam M.
    Schkeryantz, Jeffrey M.
    Mayhugh, Daniel
    Erickson, Jon A.
    Bures, Mark G.
    Jaramillo, Carlos
    Carpintero, Mercedes
    Eugenio de Diego, Jose
    Barberis, Mario
    Garcia-Cerrada, Susana
    Soriano, Jose F.
    Antonysamy, Stephen
    Atwell, Shane
    MacEwan, Lain
    Condon, Bradley
    Sougias, Christine
    Wang, Jing
    Zhang, Aiping
    Conners, Kris
    Groshong, Chris
    Wasserman, Stephen R.
    Koss, John W.
    Witkin, Jeffrey M.
    Li, Xia
    Overshiner, Carl
    Wafford, Keith A.
    Seidel, Wesley
    Wang, Xu-Shan
    Heinz, Beverly A.
    Swanson, Steven
    Catlow, John T.
    Bedwell, David W.
    Monn, James A.
    Mitch, Charles H.
    Ornstein, Paul L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (24) : 10974 - 10993
  • [37] Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A2A receptor agonist and adenosine A3 receptor antagonist activity
    Bevan, Nicola
    Butchers, Peter R.
    Cousins, Rick
    Coates, Jill
    Edgar, Emma V.
    Morrison, Val
    Sheehan, Michael J.
    Reeves, Julian
    Wilson, David J.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 564 (1-3) : 219 - 225
  • [38] Synthesis and Pharmacological Characterization of C4β-Amide-Substituted 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1S,2S,4S,5R,6S)-2-Amino-4-[(3-methoxybenzoyl)amino]bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2794193), a Highly Potent and Selective mGlu3 Receptor Agonist
    Monn, James A.
    Henry, Steven S.
    Massey, Steven M.
    Clawson, David K.
    Chen, Qi
    Diseroad, Benjamin A.
    Bhardwaj, Rajni M.
    Atwel, Shane
    Lu, Frances
    Wang, Jing
    Russell, Marijane
    Heinz, Beverly A.
    Wang, Xu-shan
    Carter, Joan H.
    Getman, Brian G.
    Adragni, Kofi
    Broad, Lisa M.
    Sanger, Helene E.
    Ursu, Daniel
    Catlow, John T.
    Swanson, Steven
    Johnson, Bryan G.
    Shaw, David B.
    McKinzie, David L.
    Hao, Junliang
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (06) : 2303 - 2328
  • [39] 4-((R)-2-{[6-((S)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than Clopidogrel
    Caroff, Eva
    Hubler, Francis
    Meyer, Emmanuel
    Renneberg, Dorte
    Gnerre, Carmela
    Treiber, Alexander
    Rey, Markus
    Hess, Patrick
    Steiner, Beat
    Hilpert, Kurt
    Riederer, Markus A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (23) : 9133 - 9153
  • [40] Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist:: In vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039)
    Rorick-Kehn, Linda M.
    Johnson, Bryan G.
    Burkey, Jennifer L.
    Wright, Rebecca A.
    Calligaro, David O.
    Marek, Gerard J.
    Nisenbaum, Eric S.
    Catlow, John T.
    Kingston, Ann E.
    Giera, Deborah D.
    Herin, Marc F.
    Monn, James A.
    McKinzie, David L.
    Schoepp, Darryle D.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (01): : 308 - 317